Development of a G118R mutation in HIV-1 integrase following a switch to dolutegravir monotherapy leading to cross-resistance to integrase inhibitors

Colaboración

Año: 2016

Brenner, BG; Thomas, R; Blanco, JL; Ibanescu, RI; Oliveira, M; Mesplede, T; Golubkov, O; Roger, M; Garcia, F; Martinez, E; Wainberg, MA

Título: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

• D1